OrbusNeich Medical Group Holdings Limited (HK:6929)
:6929
Total Valuation
OrbusNeich Medical Group Holdings Limited has a market cap or net worth of HK$3.24B. The enterprise value is HK$198.61M.
Market CapHK$3.24B
Enterprise ValueHK$198.61M
Share Statistics
OrbusNeich Medical Group Holdings Limited has 827,968,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,968,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OrbusNeich Medical Group Holdings Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.53%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)7.53%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee123.29K
Profits Per Employee31.86K
Employee Count1,331
Asset Turnover0.38
Inventory Turnover0.88
Valuation Ratios
The current PE Ratio of OrbusNeich Medical Group Holdings Limited is 9.1. OrbusNeich Medical Group Holdings Limited’s PEG ratio is -0.90.
PE Ratio9.1
PS Ratio2.41
PB Ratio1.00
Price to Fair Value1.00
Price to FCF214.47
Price to Operating Cash Flow84.29
PEG Ratio-0.90
Income Statement
In the last 12 months, OrbusNeich Medical Group Holdings Limited had revenue of 164.10M and earned 39.72M in profits. Earnings per share was 0.05.
Revenue164.10M
Gross Profit114.47M
Operating Income32.21M
Pretax Income42.41M
Net Income39.72M
EBITDA36.76M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 4.90M and capital expenditures -3.14M, giving a free cash flow of 1.76M billion.
Operating Cash Flow4.90M
Free Cash Flow1.76M
Free Cash Flow per Share<0.01
Dividends & Yields
OrbusNeich Medical Group Holdings Limited pays an annual dividend of HK$0.15, resulting in a dividend yield of 2.7%
Dividend Per ShareHK$0.15
Dividend Yield2.7%
Payout Ratio26.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change17.66%
50-Day Moving Average3.71
200-Day Moving Average4.09
Relative Strength Index (RSI)66.55
Average Volume (3m)176.23K
Important Dates
OrbusNeich Medical Group Holdings Limited upcoming earnings date is Aug 14, 2026, Before Open (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateAug 14, 2026
Ex-Dividend Date―
Financial Position
OrbusNeich Medical Group Holdings Limited as a current ratio of 11.77, with Debt / Equity ratio of 0.95%
Current Ratio11.77
Quick Ratio9.93
Debt to Market Cap0.00
Net Debt to EBITDA-6.65
Interest Coverage Ratio147.09
Taxes
In the past 12 months, OrbusNeich Medical Group Holdings Limited has paid 2.56M in taxes.
Income Tax2.56M
Effective Tax Rate0.06
Enterprise Valuation
OrbusNeich Medical Group Holdings Limited EV to EBITDA ratio is 4.10, with an EV/FCF ratio of 81.87.
EV to Sales0.92
EV to EBITDA4.10
EV to Free Cash Flow81.87
EV to Operating Cash Flow11.51
Balance Sheet
OrbusNeich Medical Group Holdings Limited has HK$248.59M in cash and marketable securities with HK$4.43M in debt, giving a net cash position of HK$244.16M billion.
Cash & Marketable SecuritiesHK$248.59M
Total DebtHK$4.43M
Net CashHK$244.16M
Net Cash Per ShareHK$0.29
Tangible Book Value Per ShareHK$0.45
Margins
Gross margin is 67.85%, with operating margin of 19.63%, and net profit margin of 24.20%.
Gross Margin67.85%
Operating Margin19.63%
Pretax Margin25.84%
Net Profit Margin24.20%
EBITDA Margin22.40%
EBIT Margin21.22%
Analyst Forecast
The average price target for OrbusNeich Medical Group Holdings Limited is HK$5.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$5.30
Price Target Upside19.37% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast11.06%
EPS Growth Forecast5.03%